Business Description
Aptorum Group Ltd
NAICS : 325412
ISIN : KYG6096M1226
Share Class Description:
XPAR:APM: Class ACompare
Compare
Traded in other countries / regions
APM.USAA1V0.GermanyAPM.France IPO Date
2020-07-24Description
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.61 | |||||
| Equity-to-Asset | 1.2 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.34 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -4.84 | |||||
| Beneish M-Score | -3.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -31 | |||||
| 3-Year EPS without NRI Growth Rate | 24.1 | |||||
| 3-Year FCF Growth Rate | 30.6 | |||||
| 3-Year Book Growth Rate | -26.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 1.18 | |||||
| Cash Ratio | 0.96 | |||||
| Days Inventory | 25.14 | |||||
| Days Sales Outstanding | 81.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.1 | |||||
| Shareholder Yield % | 47.2 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 2.32 | |||||
| Operating Margin % | -2488.17 | |||||
| Net Margin % | -655.45 | |||||
| FCF Margin % | -1789.7 | |||||
| ROE % | -13.58 | |||||
| ROA % | -15.16 | |||||
| ROIC % | -62.65 | |||||
| ROC (Joel Greenblatt) % | -427.65 | |||||
| ROCE % | -80.66 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.8 | |||||
| PB Ratio | 0.14 | |||||
| Price-to-Tangible-Book | 0.14 | |||||
| EV-to-EBIT | -0.46 | |||||
| EV-to-EBITDA | -0.51 | |||||
| EV-to-Revenue | 11.42 | |||||
| EV-to-FCF | -0.64 | |||||
| Price-to-Net-Current-Asset-Value | 0.5 | |||||
| Price-to-Net-Cash | 0.54 | |||||
| Earnings Yield (Greenblatt) % | -217.39 | |||||
| FCF Yield % | -211.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptorum Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.398 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 27 - 27 | ||
| Shares Outstanding (Mil) | 4.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptorum Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptorum Group Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptorum Group Ltd Frequently Asked Questions
What is Aptorum Group Ltd(XPAR:APM)'s stock price today?
The current price of XPAR:APM is €27.00. The 52 week high of XPAR:APM is €27.00 and 52 week low is €27.00.
When is next earnings date of Aptorum Group Ltd(XPAR:APM)?
The next earnings date of Aptorum Group Ltd(XPAR:APM) is 2024-12-20 Est..
Does Aptorum Group Ltd(XPAR:APM) pay dividends? If so, how much?
Aptorum Group Ltd(XPAR:APM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers